Research Topics
Species | Tadashi IkedaSummaryAffiliation: Keio University Country: Japan Publications
| Collaborators
|
Detail Information
Publications
The role of neoadjuvant chemotherapy for breast cancer treatmentTadashi Ikeda
Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku ku, Tokyo 160 8582, Japan
Breast Cancer 9:8-14. 2002..Core needle biopsy should be performed before neoadjuvant chemotherapy to avoid over-treatment. It is essential to develop more effective regimens and stratify patients based on predictive factors...
The evolution of primary chemotherapy in breast cancer treatmentTadashi Ikeda
Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160 8582, Japan
Breast Cancer 11:148-55. 2004..This article deals with the history of the evolution of primary chemotherapy, along with a discussion of some relevant issues...
Recent development of sentinel lymph node biopsy for breast cancer in JapanTadashi Ikeda
Department of Surgery, Keio University School of Medicine, Tokyo, Japan
Asian J Surg 27:275-8. 2004..The final decision as to whether SLNB is an adequate substitute for axillary dissection awaits the results of prospective randomized trials...
Overview: current status of breast conserving therapy in JapanTadashi Ikeda
Department of Surgery, Keio University Hospital, 35 Shinanomachi, Shinjuku, Tokyo 160 8582, Japan
Biomed Pharmacother 56:182s-186s. 2002..The current status of breast conserving operations in Japan is reviewed in comparison with their status in Western countries...
Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastasesYoshifumi Komoike
Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan
Cancer 106:35-41. 2006..The purpose of this study was to clarify risk factors of IBTR and the impact of IBTR on development of distant metastases in this ethnic group...
Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasisHiromitsu Jinno
Department of Surgery, Keio University School of Medicine, Tokyo, Japan
Breast J 14:551-5. 2008..In breast cancer patients with a positive SLN, lymphatic invasion and the number of tumor-involved SLNs were both independent predictors of non-SLN involvement...
Stereoscopic scintigraphic imaging of breast cancer sentinel lymph nodesChikako Tanaka
Department of Radiology, Keio University School of Medicine, Japan
Breast Cancer 14:92-9. 2007..Conventional planar scintigraphy cannot provide three-dimensional(3D) information for SLN biopsy. We applied stereoscopic imaging to preoperative lymphoscintigraphy to obtain 3D information and evaluated its usefulness...
Increasing age does not affect efficacy of sentinel lymph node biopsy using smaller-sized technetium-99m tin colloids for breast cancer patientsHiromitsu Jinno
Department of Surgery, Keio University School of Medicine, Shinjuku ku, Tokyo 160, Japan
Am J Surg 190:51-4. 2005..Increasing age of breast cancer patients was reported to cause not only failure of sentinel lymph node (SLN) identification but also false negative results...
[Predictive factors affect the choice of strategy for breast cancer surgery]Tadashi Ikeda
Department of Surgery, Keio University School of Medicine, Tokyo, Japan
Nippon Geka Gakkai Zasshi 103:799-802. 2002..Predictive factors for the effect of radiation therapy should also be taken into account after breast-conserving surgery. It remains to be determined which predictive factors should be considered at which time...
[Breast cancer]Tadashi Ikeda
Department of Surgery, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
Gan To Kagaku Ryoho 29:1509-15. 2002..To perform good clinical trials, it is imperative to construct infrastructures including clinical research coordinator, and abolish governmental regulation of the dose of anticancer agents...
[Adjuvant chemotherapy for breast cancer--a current controversy]Hiromitsu Jinno
Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
Gan To Kagaku Ryoho 31:176-80. 2004..Dose-dense therapy seems promising but still needs further investigation. Incorporation of taxanes into adjuvant chemotherapy for early breast cancer is also controversial...
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumorsYoshifumi Komoike
Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1 3 3 Nakamichi, Higashinari ku, Osaka 537 8511, Japan
Breast Cancer 12:104-11. 2005..The aim of this study is to clarify the biological difference between TR and NP, and to show the clinical significance of classifying IBTR into these two types of recurrence...
[The evolving role of endocrine therapy for breast cancer]Hiromitsu Jinno
Department of Surgery, Keio University School of Medicine
Nippon Rinsho 64:547-54. 2006....
Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgeryTakeshi Tominaga
Breast Cancer Center, Toyosu Hospital, Showa University School of Medicine, Tokyo, Japan
J Clin Oncol 21:991-8. 2003....
Lymphoscintigraphy for the visualization of sentinel lymph nodes and body contourHirofumi Fujii
Department of Radiology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku ku, Tokyo 160 8582, Japan
Breast Cancer 11:250-5; discussion 264-6. 2004..This clarity needs to reach a level where the sentinel lymph nodes (SLNs) and the body contour are clearly visible. We have developed a simple image processing method using the division of primary and scattered photon counts...
Chemosensitivity-related genes of breast cancer detected by DNA microarrayTadashi Ikeda
Department of Surgery, Keio University School of Medicine, Tokyo, Japan
Anticancer Res 27:2649-55. 2007..The feasibility of a preoperative docetaxel/5'-deoxy-5-fluorouridine (5'-DFUR) regimen for breast cancer patients was examined and the genes related to the response to it was investigated...
[Current status of sentinel node adenectomy and future perspectives]Tadashi Ikeda
Department of Surgery, Keio University Hospital, Tokyo, Japan
Nippon Geka Gakkai Zasshi 105:480-4. 2004..and a trial to detect lymphatic flow with CT after local injection of contrast medium is also being conducted. Sentinel node adenectomy may become a standard technique for early breast cancer patients in the near future...
Identification of a new breast cancer-related gene by restriction landmark genomic scanningSota Asaga
Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku ku, Tokyo, 160 8582, Japan
Anticancer Res 26:35-42. 2006..Although several prognostic markers have already been identified for breast cancer, it is clear that others remain to be identified...
Evaluation of novel modified tangential irradiation technique for breast cancer patients using dose-volume histogramsAtsuya Takeda
Department of Radiology, Keio University School of Medicine and Tokyo Metropolitan Hiroo Hospita, Tokyo, Japan
Int J Radiat Oncol Biol Phys 58:1280-8. 2004....
Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizesHiromitsu Jinno
Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku ku, Tokyo 160, Japan
Biomed Pharmacother 56:213s-216s. 2002..It was concluded that SLNB using the small-sized tin colloid was technically feasible and provided higher detection and identification rates than the regular-sized tin colloid...
Emerging patterns of practice in the implementation and application of sentinel lymph node biopsy in breast cancer patients in JapanTadashi Ikeda
Department of Surgery, Keio University School of Medicine, Tokyo, Japan
J Surg Oncol 84:173-5. 2003
Combination chemotherapy with docetaxel and doxifluridine showed a beneficial outcome in advanced or recurrent breast cancer patients with longer disease-free intervalReiki Nishimura
Department of Surgery, Kumamoto City Hospital, 1 1 60 Kotoh, Kumamoto 862 8505, Japan
Anticancer Res 24:2085-91. 2004..CONCLUSION: The good response rate and long TTP of this doxifluridine plus docetaxel regimen indicate its potential as a first- or second-line treatment for advanced/recurrent breast cancer patients...
Prevention of mammary carcinogenesis in C3H/OuJ mice by green tea and tamoxifenMichio Sakata
Department of Surgery, School of Medicine, Keio University, Tokyo, Japan
Asian Pac J Cancer Prev 12:567-71. 2011..In this study, we investigated their effects, alone or in combination, on mammary carcinogenesis using breast cancer cells and preneoplastic lesions inC3H/OuJ mice...
ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3Yoko Mitsui
Department of Pathology, School of Medicine, Keio University, Shinjuku ku, Tokyo, Japan
Cancer Res 66:9913-20. 2006....
New challenges in the field of breast cancer therapy-do we need surgery for the patients with breast cancer?Tadashi Ikeda
Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan
Breast Cancer 14:37-8. 2007
Efficacy of an MPC-BMA co-polymer as a nanotransporter for paclitaxelMasahiro Wada
Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku ku, Tokyo 160 8582, Japan
Anticancer Res 27:1431-5. 2007..Paclitaxel (PTX) is administered as a solution in polyoxyethylated castor oil (CO) due to its low water solubility, but solvent-induced side-effects may be severe...
Phase I study of docetaxel and cyclophosphamide in patients with advanced or recurrent breast cancerTadao Shimizu
Department of Surgery, Tokyo Women s Medical University Daini Hospital, 2 1 10 Nishiogu, Arakawa ku, Tokyo 116 8567, Japan
Breast Cancer 10:140-8. 2003....
The cytotoxicity of a conjugate composed of human epidermal growth factor and eosinophil cationic proteinHiromitsu Jinno
Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160, Japan
Anticancer Res 22:4141-5. 2002..CONCLUSION: Conjugates composed solely of human proteins might be useful with less immunogenicity and less toxicity than the conventional immunotoxins for targeted therapy...
Outcomes of Japanese breast cancer patients treated with pre-operative and post-operative anastrozole or tamoxifenYasuhiro Fujiwara
National Cancer Center Hospital, Tokyo, Japan
Cancer Sci 103:491-6. 2012..Most patients responding to pre-operative therapy remained recurrence-free. Sequential pre-operative/post-operative treatment with anastrozole resulted in lower recurrence and death rates, compared with tamoxifen...
The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expressionShin Takayama
Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku ku, Tokyo, Japan
Anticancer Res 25:79-83. 2005..Integrin alpha(v)beta3 mediates the attachment of osteoclasts to bone matrix, and it is overexpressed in bone-residing breast cancer cells. We studied BM from breast cancer in relation to its Integrin alpha(v)beta3 expression...
Effects of toremifene and anastrozole on serum lipids and bone metabolism in postmenopausal females with estrogen receptor-positive breast cancer: the results of a 2-year multicenter open randomized studyKeisei Anan
Department of Surgery, Kitakyushu Municipal Medical Center, Fukuoka, Japan
Breast Cancer Res Treat 128:775-81. 2011..However, the serum BAP increase was not significant at 24 months. TOR provides better effects than ANA in terms of lipid profiles and bone metabolism in postmenopausal females with early breast cancer...
[Intra-arterial infusion chemotherapy for breast cancer]Hideyuki Tokura
Department of Surgery, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
Gan To Kagaku Ryoho 29:176-81. 2002..Accordingly, further studies including combined use of systemic chemotherapy are mandatory to the control of micrometastases outside the target organ...
[Future directions of anticancer drug development in Japan]Hideyuki Akaza
Urology, University of Tsukuba
Gan To Kagaku Ryoho 35:351-60. 2008..The number of Japanese patients necessary for Phase III studies is individual developmental strategy and needs to be examined by both companies and regulatory agencies...
Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapyMasakazu Toi
Department of Surgery Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto 606 8507, Japan
Int J Oncol 31:899-906. 2007..After 2 years, the RPV of TS decreased with time, suggesting that 2 years of treatment with oral fluorouracil derivatives may be inadequate. Further studies are required to investigate this possibility...
Long-term results of breast-conserving treatment for early-stage breast cancer in Japanese women from multicenter investigationShozo Ohsumi
National Shikoku Cancer Center, Matsuyama, Japan
Jpn J Clin Oncol 33:61-7. 2003..Although many clinical data regarding breast-conserving treatment have already been reported from European and North American countries, few clinical data with long-term follow-up have been reported from Japan...
[Globalization of clinical trials]Hideyuki Akaza
Dept. of Urology, Institute of Clinical Medicine, University of Tsukuba
Gan To Kagaku Ryoho 30:555-65. 2003..If we can address these issues Japanese investigators and collaborative groups should be able to initiate and lead global trials in the future...
[Present status and future perspective of surgical therapy for breast neoplasms]Tadashi Ikeda
Department of Surgery, Teikyo University School of Medicine
Nippon Rinsho 65:434-8. 2007
Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancerToshiaki Saeki
National Shikoku Cancer Center, Matsuyama, Japan
J Clin Oncol 25:411-7. 2007..Dofequidar is a novel, orally active quinoline derivative that reverses multidrug resistance...
1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery: a randomized controlled trialTakeshi Tominaga
Breast Cancer Center, Toyosu Hospital, Showa University School of Medicine, Tokyo 135 8577, Japan
Oncol Rep 12:797-803. 2004..Study results suggest that 2-year HCT therapy including the oral 5-FU anti-cancer drug HCFU is a useful adjuvant therapy which can replace CMFT therapy in early breast cancer cases with 3 or lower metastatic lymph nodes...
Inhibition of bone metastasis from breast cancer with pamidronate resulting in reduction of urinary pyridinoline and deoxypyridinoline in a rat modelNoriaki Wada
Division of Breast Surgery, National Cancer Center Hospital East, 6 5 1 Kashiwanoha Kashiwa Chiba, 277 8577, Japan
Breast Cancer 11:282-7. 2004....
[Developments in endocrine therapy for breast cancer]Akira Matsui
Keio Cancer Center, Keio University Hospital
Gan To Kagaku Ryoho 29:1138-45. 2002..Currently, many clinical randomized trials are being conducted to examine the effectiveness of new endocrine treatment. Significant changes are occurring in the endocrine treatment of breast cancer...
Impact of left atrial volume reduction concomitant with atrial fibrillation surgery on left atrial geometry and mechanical functionAkira Marui
Department of Cardiovascular Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
J Thorac Cardiovasc Surg 135:1297-305. 2008..We sought to investigate the perioperative factors that influence left atrial geometry and mechanical functions after the Maze procedure in patients with refractory atrial fibrillation and left atrial enlargement...
[Globalization of anti-cancer therapies]Hideyuki Akaza
Dept. of Urology, Institute of Clinical Medicine, University of Tsukuba
Gan To Kagaku Ryoho 29:205-14. 2002..There have been some recent improvements and further progress is expected so that Japanese doctors can play a full role in the evaluation of new therapies...
Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trialMasafumi Kurosumi
Saitama Cancer Center, 818 Komuro, Ina machi, Kitaadachi gun, Saitama 362 0806, Japan
J Cancer Res Clin Oncol 134:715-22. 2008....
[Post launch studies]Hideyuki Akaza
Dept. of Urology, Institute of Clinical Medicine, University of Tsukuba, Japan
Gan To Kagaku Ryoho 29:2037-48. 2002..In fact, researcher-initiated clinical trials achieved a rapid growth in Japan in the past year...
Early and mid-term results of left ventricular volume reduction surgery for dilated cardiomyopathyTadaaki Koyama
Department of Cardiovascular Surgery, Kyoto University, Graduate School of Medicine, Sakyo-ku Kyoto, Japan
J Card Surg 20:S39-42. 2005..8% and 93.8%, respectively (p = 0.099). CONCLUSIONS: Early and mid-term results of LVVRS were satisfied, and the non-Dor operation tended to be superior in mid-term survival to the Dor operation. Long-term follow-up is warranted...
Invasive lobular carcinoma arising in phyllodes tumor of the breastTakahide Kodama
Virchows Arch 442:614-6. 2003
Antitumor effect of combination of S-1 and docetaxel on the human breast cancer xenograft transplanted into SCID miceAkihiko Suto
Department of Surgery Yamato Municipal Hospital, 8 3 6 Fukami nishi, Yamato City Kanagawa 242 8602, Japan
Oncol Rep 15:1517-22. 2006..Down-regulation of the DPD activity of the tumors is also considered to be correlated with the antitumor effect of the treated groups, suggesting its influence on the synergistic effect of the combination therapy...
To overcome breast cancer with all of our knowledgeTadashi Ikeda
Breast Cancer 15:8-9. 2008
